Sign in

CIK 0001878313

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
Open-market buys, last 90 days
$352,317
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Guerrero Ramiro +$252K Director 4 filings
  2. Vitoc Vlad +$100K Chief Executive Officer 1 filing

Reading 36 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Obrocea Mihail Chief Medical Officer Grant or award · Stock Options +87,495 87,495
2023-03-08 Obrocea Mihail Chief Medical Officer Grant or award · Stock Options +100,000 100,000

Page 1 of 1 · 2 trades